Neurotoxicity of L-glutamate and DL-threo-3-hydroxyaspartate in the rat striatum.
Destruction of the glutamatergic corticostriatal pathway potentiates the neurotoxic action of 1 mumol L-glutamate injected into the rat striatum, whereas the toxic effects of 10 nmol kainate are markedly attenuated. Injection of 170 nmol of the glutamate uptake inhibitor, DL-threo-3-hydroxyaspartate, into the intact striatum also causes neuronal degeneration, which is accompanied by a reduction in markers for cholinergic and GABAergic neurones. Prior removal of the corticostriatal pathway destroys the ability of DL-threo-3-hydroxyaspartate to cause lesions in the striatum. These results indicate that removal, or blockade, of uptake sites for glutamate increase the vulnerability of striatal neurones to the toxic effects of synaptically released glutamate.
McBean
G J
GJ
Roberts
P J
PJ
D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000633:toxicity; D003342:Corpus Striatum / Q000187:drug effects* / Q000473:pathology; D005260:Female; D005971:Glutamates / Q000633:toxicity*; D018698:Glutamic Acid; D007608:Kainic Acid / Q000633:toxicity; D051381:Rats; D011919:Rats, Inbred Strains
D005971:Glutamates; C011274:3-hydroxyaspartic acid; D001224:Aspartic Acid; D018698:Glutamic Acid; D007608:Kainic Acid